• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1120300-08
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Dyspnea (1816)
Event Date 08/15/2018
Event Type  Injury  
Manufacturer Narrative
The stent remains in patient.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
Patient no: (b)(6).It was reported that on (b)(6) 2017, a 3.0 x 8 mm xience alpine stent was successfully implanted.Final optical coherence tomography (oct) noted good stent apposition.On (b)(6) 2018, the patient presented with chest pain and was hospitalized.Evaluation was performed and the patient was discharged on (b)(6) 2018.No additional information was provided.
 
Event Description
Patient id: (b)(6).Subsequent to the initial 30-day medwathc report, the following information was provided.The index procedure was performed on (b)(6)2017 to treat a lesion in the mid left anterior descending coronary artery.On (b)(6)2018 , the patient was re-hospitalized with chest pain and dyspnea.The patient was admitted for evaluation; however, no additional intervention was performed.The patient was discharged to home, with instructions to follow up at the cardiology outpatient department.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect of angina is listed in the xience alpine everolimus eluting coronary stent systems instructions for use as a known patient effect(s) of coronary procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.B3 :date of event.D6: implant date corrected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10311597
MDR Text Key199984375
Report Number2024168-2020-06135
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 09/04/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/13/2019
Device Catalogue Number1120300-08
Device Lot Number6120741
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/02/2020
Initial Date FDA Received07/22/2020
Supplement Dates Manufacturer Received08/17/2020
Supplement Dates FDA Received09/04/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age64 YR
-
-